Presentation is loading. Please wait.

Presentation is loading. Please wait.

Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer  Akihito Watanabe, MD, Masao Hosokawa, MD,

Published byHollie Harmon Modified over 5 years ago

Similar presentations

Presentation on theme: "Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer  Akihito Watanabe, MD, Masao Hosokawa, MD,"— Presentation transcript:

1 Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer  Akihito Watanabe, MD, Masao Hosokawa, MD, Masanobu Taniguchi, MD, Shigeyuki Sasaki, MD  The Annals of Thoracic Surgery  Volume 76, Issue 5, Pages (November 2003) DOI: /S (03)

2 Fig 1 Kaplan-Meier survival curves for patients with esophageal cancer without squamous cell carcinoma of the head and neck (EC group) and patients with esophageal cancer and metachronous or synchronous development of squamous cell carcinoma of the head and neck (EC+SCCHN group). There was no significant difference between the two groups. The Annals of Thoracic Surgery  , DOI: ( /S (03) )

3 Fig 2 Kaplan-Meier survival curves for patients undergoing surgical resection. There was no significant difference between the two groups. (EC group = patients with esophageal cancer without squamous cell carcinoma of the head and neck; EC+SCCHN group = patients with esophageal cancer and metachronous or synchronous development of squamous cell carcinoma of the head and neck.) The Annals of Thoracic Surgery  , DOI: ( /S (03) )

4 Fig 3 Kaplan-Meier survival curves for patients receiving periodic pharyngolaryngoscopy. There was no significant difference between the two groups. (EC group = patients with esophageal cancer without squamous cell carcinoma of the head and neck; EC+SCCHN group = patients with esophageal cancer and metachronous or synchronous development of squamous cell carcinoma of the head and neck.) The Annals of Thoracic Surgery  , DOI: ( /S (03) )

5 Fig 4 Kaplan-Meier survival curves for patients undergoing periodic pharyngolaryngoscopy (periodical endoscopic screening [+]) and patients without screenings (periodical endoscopic screening [−]). The survival rate for patients receiving screening was significantly better than that for the other group (**p < 0.001). The Annals of Thoracic Surgery  , DOI: ( /S (03) )

6 Fig 5 Kaplan-Meier survival curves for patients undergoing surgical resection and then followed with (periodical endoscopic screening [+]) or without (periodical endoscopic screening [−]) periodic pharyngolaryngoscopy. Note that only patients who had surgical resection are included. The survival rate for patients undergoing periodic screening was significantly better than that of the other group (**p < 0.01). The Annals of Thoracic Surgery  , DOI: ( /S (03) )

Download ppt "Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer  Akihito Watanabe, MD, Masao Hosokawa, MD,"

Similar presentations

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Improved clinical outcomes in patients undergoing coronary artery bypass grafting with coronary endarterectomy  Oz M Shapira, MD, Gabriel Akopian, Ali.

Improved clinical outcomes in patients undergoing coronary artery bypass grafting with coronary endarterectomy  Oz M Shapira, MD, Gabriel Akopian, Ali.
Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD 

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD 
Primary non-Hodgkin’s lymphoma of the lung

Primary non-Hodgkin’s lymphoma of the lung
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
Clinicopathological and biological assessment of lung cancers with pleural dissemination  Yasuhiko Ohta, MD, Yoko Tanaka, PhD, Takuo Hara, MD, Makoto.

Clinicopathological and biological assessment of lung cancers with pleural dissemination  Yasuhiko Ohta, MD, Yoko Tanaka, PhD, Takuo Hara, MD, Makoto.
Puja Gaur, MD, Wayne L. Hofstetter, MD, B

Puja Gaur, MD, Wayne L. Hofstetter, MD, B
Amiodarone Significantly Decreases Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer  Lars P. Riber, MD, PhD, Thomas D. Christensen,

Amiodarone Significantly Decreases Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer  Lars P. Riber, MD, PhD, Thomas D. Christensen,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.

Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.
Percutaneous endoscopic gastrostomy before multimodality therapy in patients with esophageal cancer  Marc Margolis, MD, Pendleton Alexander, MD, Gregory.

Percutaneous endoscopic gastrostomy before multimodality therapy in patients with esophageal cancer  Marc Margolis, MD, Pendleton Alexander, MD, Gregory.
Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer  José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer  José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,
Epidermal Growth Factor Receptor Is a Prognosis Predictor in Patients With Esophageal Squamous Cell Carcinoma  Wencheng Zhang, MD, Hongxia Zhu, MD, Xiao.

Epidermal Growth Factor Receptor Is a Prognosis Predictor in Patients With Esophageal Squamous Cell Carcinoma  Wencheng Zhang, MD, Hongxia Zhu, MD, Xiao.
Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer  Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke.

Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer  Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke.
A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients  Elizabeth A. David, MD, Stina W. Andersen, PhD,

A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients  Elizabeth A. David, MD, Stina W. Andersen, PhD,
Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life  Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,

Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life  Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,
Prognostic Variables in Thoracic Esophageal Squamous Cell Carcinoma

Prognostic Variables in Thoracic Esophageal Squamous Cell Carcinoma
David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

Similar presentations

Ads by Google